Cost-effectiveness of apixaban vs. current standard of care for stroke prevention in patients with atrial fibrillation
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cost-effectiveness of apixaban vs. current standard of care for stroke prevention in patients with atrial fibrillation
Authors
Keywords
-
Journal
EUROPEAN HEART JOURNAL
Volume 35, Issue 28, Pages 1897-1906
Publisher
Oxford University Press (OUP)
Online
2014-02-11
DOI
10.1093/eurheartj/ehu006
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cost-Effectiveness of Dabigatran Compared With Warfarin for Stroke Prevention in Atrial Fibrillation
- (2013) James V. Freeman et al. ANNALS OF INTERNAL MEDICINE
- Efficacy and Safety of Apixaban Compared With Warfarin at Different Levels of Predicted International Normalized Ratio Control for Stroke Prevention in Atrial Fibrillation
- (2013) Lars Wallentin et al. CIRCULATION
- Cost-Effectiveness of Apixaban, Dabigatran, Rivaroxaban, and Warfarin for Stroke Prevention in Atrial Fibrillation
- (2013) Amanda R. Harrington et al. STROKE
- Stroke and Thromboembolism in Atrial Fibrillation
- (2012) Ron Pisters et al. CIRCULATION JOURNAL
- 2012 focused update of the ESC Guidelines for the management of atrial fibrillation
- (2012) et al. EUROPEAN HEART JOURNAL
- Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trial
- (2012) J Donald Easton et al. LANCET NEUROLOGY
- Cost-effectiveness of apixaban vs warfarin for secondary stroke prevention in atrial fibrillation
- (2012) H. Kamel et al. NEUROLOGY
- Cost-Effectiveness of Apixaban Compared with Warfarin for Stroke Prevention in Atrial Fibrillation
- (2012) Soyon Lee et al. PLoS One
- State-Transition Modeling: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-3
- (2012) Uwe Siebert et al. VALUE IN HEALTH
- Catalogue of EQ-5D Scores for the United Kingdom
- (2011) Patrick W. Sullivan et al. MEDICAL DECISION MAKING
- Apixaban in Patients with Atrial Fibrillation
- (2011) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Apixaban versus Warfarin in Patients with Atrial Fibrillation
- (2011) Christopher B. Granger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Risks of stroke and mortality associated with suboptimal anticoagulation in atrial fibrillation patients
- (2011) Arlene Gallagher et al. THROMBOSIS AND HAEMOSTASIS
- Underuse of Oral Anticoagulants in Atrial Fibrillation: A Systematic Review
- (2010) Isla M. Ogilvie et al. AMERICAN JOURNAL OF MEDICINE
- Human and economic burden of stroke
- (2009) A. Di Carlo AGE AND AGEING
- Cost-effectiveness of warfarin: Trial versus “real-world” stroke prevention in atrial fibrillation
- (2009) Sonja V. Sorensen et al. AMERICAN HEART JOURNAL
- Survival after stroke — The impact of CHADS2 score and atrial fibrillation
- (2009) Karin M. Henriksson et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Restarting Anticoagulation Therapy After Warfarin-Associated Intracerebral Hemorrhage
- (2008) Daniel O. Claassen et al. ARCHIVES OF NEUROLOGY
- The Prognostic Value of the Modified Rankin Scale Score for Long-Term Survival after First-Ever Stroke
- (2008) Krista F. Huybrechts et al. CEREBROVASCULAR DISEASES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now